ARQUIVOS BRASILEIROS DE OFTALMOLOGIA is a prominent peer-reviewed journal dedicated to the field of ophthalmology, published by CONSEL BRASIL OFTALMOLOGIA since its inception in 1945. With its commitment to disseminating high-quality research, the journal has transitioned to an Open Access model since 2001, ensuring that vital findings in ophthalmology are freely available to researchers, clinicians, and students alike. Located in São Paulo, Brazil, this esteemed publication occupies a significant position in the medical field, currently holding a Q3 ranking in both the miscellaneous medicine and ophthalmology categories. Although it maintains a legacy of fluctuating impact, recognized for its contribution to the academic community, ARQUIVOS BRASILEIROS DE OFTALMOLOGIA continues to attract a diverse international readership, making it a valuable resource for advancements in eye health, surgical techniques, and ocular research.

The Indian Journal of Ophthalmology is a prestigious, peer-reviewed publication dedicated to advancing the field of ophthalmology. Published by Wolters Kluwer Medknow Publications, this journal plays a vital role in disseminating high-quality research and clinical insights since its inception in 1946. With an impact factor placing it in the Q2 category in Ophthalmology for 2023, it ranks #42 out of 137 in Scopus, reflecting its influence and reliability in the medical community. As an Open Access journal since 2005, it ensures that impactful research is accessible to a global audience, fostering innovation and knowledge sharing among researchers, healthcare professionals, and students alike. The journal's commitment to publishing cutting-edge studies, comprehensive reviews, and clinical guidelines makes it an essential resource for those navigating the rapidly evolving landscape of eye care and ophthalmology.

Ophthalmology Glaucoma is a premier academic journal dedicated to advancing the understanding and management of glaucoma, a leading cause of irreversible blindness worldwide. Published by Elsevier, this journal covers a broad spectrum of topics within the field of ophthalmology, providing a platform for groundbreaking research and clinical insights. With an impressive impact factor that places it in the Q1 category of ophthalmology journals, and a commendable Scopus ranking of 29 out of 137, Ophthalmology Glaucoma is recognized for its rigorous peer-review process and high-quality publications. Since its inception in 2018, the journal has focused on disseminating innovative findings and treatment modalities to enhance patient care and outcomes. Researchers, clinicians, and students are encouraged to explore the Open Access options available, promoting wider accessibility to critical scientific knowledge. By staying at the forefront of ophthalmic research, Ophthalmology Glaucoma plays an essential role in shaping practices and policies that improve eye health globally.

Clinical and Experimental Optometry, published by Taylor & Francis Ltd, is a distinguished journal dedicated to advancing the field of optometry and ophthalmology. With an impressive scope covering both clinical practices and experimental research, this journal serves as a vital resource for researchers, healthcare professionals, and students alike. Recognized in the Q2 category for Ophthalmology and Q1 category for Optometry in 2023, it underscores its significance in fostering innovative research and clinical knowledge. The journal has been in publication since 1986 and continues to accept contributions up until 2024, reflecting its ongoing commitment to disseminating high-quality scholarly work. With a Scopus ranking of 40 in Ophthalmology and 5 in Health Professions - Optometry, it is positioned among the leading journals in the field. Although not an open-access journal, it remains integral for anyone invested in the latest trends and findings in vision science, making it an essential part of the academic landscape in the UK and beyond.

The International Journal of Ophthalmology, with ISSN 2222-3959 and E-ISSN 2227-4898, is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by IJO PRESS in China, this journal has been a valuable resource since its inception in 2005, providing a platform for groundbreaking research and clinical studies in ophthalmic science. With an impressive Q2 ranking in the 2023 Ophthalmology category and a Scopus rank of #65 out of 137, the journal consistently showcases high-quality articles that contribute significantly to the understanding and treatment of eye diseases. Since adopting an open-access model in 2010, it has expanded its reach, allowing researchers, professionals, and students worldwide to access vital knowledge in the field. The journal aims to bridge the gap between laboratory research and clinical practice, making it an essential resource for those committed to improving visual health and advancing ophthalmologic education and innovation.

JAMA Ophthalmology, the premier journal in the field of ophthalmology, is published by the esteemed American Medical Association. Renowned for its rigorous peer-review process and commitment to advancing eye health research, JAMA Ophthalmology holds a prestigious position in the scientific community, boasting an impressive impact factor and ranking as Q1 in the category of Ophthalmology. With a Scopus rank of #3 out of 137 in its field and a remarkable 98th percentile, the journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to the ophthalmic sciences. Readers can explore a wealth of cutting-edge findings, clinical studies, and review articles that not only contribute to the sustainable advancement of ophthalmic knowledge but also foster innovative approaches in patient care. As we converge into 2024, the journal continues to embrace open access principles, ensuring that groundbreaking research is readily available to a global audience, enhancing collaborative efforts and furthering the development of the ophthalmology discipline.

Ophthalmology and Therapy is a premier open-access journal published by Springer International Publishing AG, dedicated to advancing the field of ophthalmology through innovative research and clinical studies. With an ISSN of 2193-8245 and an E-ISSN of 2193-6528, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in eye care and vision science. The journal has achieved a remarkable impact factor and has been recognized as a Q1 journal in Ophthalmology, reflecting its contributions to the discipline and its high-quality publications. Operating from the United Kingdom, Ophthalmology and Therapy is an open-access platform that has been available since 2012, ensuring that critical research is accessible to a global audience. Its commitment to fostering collaboration and knowledge sharing is exemplified by its ranking of #39 out of 137 in the Scopus category for Medicine – Ophthalmology, placing it in the 71st percentile of its peers. Together, these attributes highlight the journal's importance as a key forum for the dissemination of cutting-edge research, making it an essential addition to the libraries of institutions and professionals engaged in ophthalmic care.

Translational Vision Science & Technology is a premier open access journal dedicated to the advancement of the field of ophthalmology and biomedical engineering. Published by the Association for Research in Vision and Ophthalmology, Inc., this journal has established itself as a leading source of high-quality research since its inception in 2013, achieving a remarkable impact factor reflective of its influential contribution to the field. With an impressive ranking of #21 in Ophthalmology and #120 in Biomedical Engineering within the Scopus database, it sits within the prestigious Q1 quartile for both categories as of 2023, further validating its significance. The journal's scope encompasses a wide variety of topics focused on the intersection of ophthalmological science and technological innovation, welcoming contributions that promote the understanding and treatment of visual disorders. Available as an Open Access publication since 2016, it ensures that cutting-edge research is freely accessible to researchers, practitioners, and students worldwide, facilitating the rapid dissemination of knowledge essential for the advancement of vision science.

The Middle East African Journal of Ophthalmology is a distinguished publication dedicated to advancing knowledge in the field of ophthalmology, published by Wolters Kluwer Medknow Publications in India. With a robust focus on contributions that bridge the gap between clinical practices and scientific research, this journal serves as a crucial platform for researchers, practitioners, and students alike. Since its inception, it has consistently disseminated high-impact research, achieving notable recognition with a Q3 ranking in both Medicine (miscellaneous) and Ophthalmology categories as of 2023. Despite being a newer entrant into the scholarly landscape, it features an array of innovative articles, highlighting significant advancements and emerging trends in ocular health. Researchers may access a wealth of knowledge through its open access articles, promoting the dissemination of vital ophthalmic research that is relevant in both Middle Eastern and African contexts. By fostering collaboration and communication among professionals in the field, the Middle East African Journal of Ophthalmology is committed to championing excellence in eye care and elevating the standard of research applicable to global populations.

American Journal of Ophthalmology, published by Elsevier Science Inc, stands as a premier outlet for significant advancements in the field of ophthalmology. Established in 1918, this journal has a long-standing tradition of disseminating high-quality research, which is reflected in its impressive Scopus ranking, positioned at #8 out of 137 in the ophthalmology category, placing it in the 94th percentile. With its 2023 designation as Q1 in Ophthalmology, it serves as a critical platform for researchers, practitioners, and students who seek to stay at the forefront of ocular health and visual science. Although the journal does not currently offer open access options, it provides an array of access formats, ensuring that valuable research is available to a broad audience dedicated to the exploration and understanding of eye diseases and treatments. As it continues to evolve towards 2024, the American Journal of Ophthalmology remains essential for anyone engaged in ophthalmic research and clinical practice.